Literature DB >> 27122887

The Relationship between Expressive/Suppressive Hostility Behavior and Cardiac Autonomic Activations in Patients with Coronary Artery Disease.

I-Mei Lin1, Chia-Ying Weng2, Tin-Kwang Lin3, Chin-Lon Lin4.   

Abstract

BACKGROUND: Hostility is an important psychosocial risk factor in coronary artery disease (CAD). Expressive and suppressive hostility behaviors are related to cardiovascular response in healthy adults. However, the relationships of these behavioral dimensions to cardiac autonomic activations in CAD remain unclear.
METHOD: This study involved 76 patients with CAD to whom a hostility inventory was administered, who were instructed to recall a neutral event and an anger-related event. Heart rate and blood pressure were obtained for each patient as the indices of cardiovascular response; heart rate variability was transformed from electrocardiograph and as the indices of cardiac autonomic activation.
RESULTS: The results showed that CAD patients with expressive hostility behavior experienced higher cardiovascular autonomic activations during the neutral and anger recall tasks, and lower parasympathetic activations during the recovery after an anger episode. On the other hand, CAD patients with suppressive hostility behavior experienced both sympathetic and parasympathetic activations during the baseline and recovery stages, as well as simultaneously activated higher parasympathetic response.
CONCLUSIONS: The results of this study suggested that it is appropriate to extend the cardiac autonomic activation model for expressive and suppressive hostility behaviors in patients with CAD. KEY WORDS: Cardiac autonomic; Coronary artery disease; Expressive hostility; Suppressive hostility behaviors.

Entities:  

Year:  2015        PMID: 27122887      PMCID: PMC4804927          DOI: 10.6515/acs20141027b

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  44 in total

1.  An inventory for assessing different kinds of hostility.

Authors:  A H BUSS; A DURKEE
Journal:  J Consult Psychol       Date:  1957-08

2.  The moderating effects of gender on the associations between multidimensional hostility and psychosomatic symptoms: a Chinese case.

Authors:  Chia-Ying Weng; I-Mei Lin; Ding-Yu Jiang
Journal:  Int J Psychol       Date:  2010-08-01

3.  Prolonged cardiac effects of momentary assessed stressful events and worry episodes.

Authors:  Suzanne Pieper; Jos F Brosschot; Rien van der Leeden; Julian F Thayer
Journal:  Psychosom Med       Date:  2010-04-21       Impact factor: 4.312

4.  Antagonistic behavior, dominance, hostility, and coronary heart disease.

Authors:  A W Siegman; S T Townsend; A C Civelek; R S Blumenthal
Journal:  Psychosom Med       Date:  2000 Mar-Apr       Impact factor: 4.312

5.  Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.

Authors:  Marian B Olson; David S Krantz; Sheryl F Kelsey; Carl J Pepine; George Sopko; Eileen Handberg; William J Rogers; Gretchen L Gierach; Candace K McClure; C Noel Bairey Merz
Journal:  Psychosom Med       Date:  2005 Jul-Aug       Impact factor: 4.312

6.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.

Authors:  M T La Rovere; J T Bigger; F I Marcus; A Mortara; P J Schwartz
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

7.  Adrenocorticotropin responses to interpersonal stress: effects of overt anger expression style and defensiveness.

Authors:  M al'Absi; S Bongard; W R Lovallo
Journal:  Int J Psychophysiol       Date:  2000-09       Impact factor: 2.997

8.  The aggression questionnaire.

Authors:  A H Buss; M Perry
Journal:  J Pers Soc Psychol       Date:  1992-09

9.  Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.

Authors:  Rachel Lampert; Jeannette R Ickovics; Catherine J Viscoli; Ralph I Horwitz; Forrester A Lee
Journal:  Am J Cardiol       Date:  2003-01-15       Impact factor: 2.778

10.  Components of hostility and the severity of coronary artery disease.

Authors:  A W Siegman; T M Dembroski; N Ringel
Journal:  Psychosom Med       Date:  1987 Mar-Apr       Impact factor: 4.312

View more
  5 in total

1.  The Effects of Heart Rate Variability (HRV) Biofeedback on HRV Reactivity and Recovery During and After Anger Recall Task for Patients with Coronary Artery Disease.

Authors:  I-Mei Lin; Pei-Yun Lin; Sheng-Yu Fan
Journal:  Appl Psychophysiol Biofeedback       Date:  2022-03-09

2.  Heart rate dynamics in the prediction of coronary artery disease and myocardial infarction using artificial neural network and support vector machine.

Authors:  Rahul Kumar; Yogender Aggarwal; Vinod Kumar Nigam
Journal:  J Appl Biomed       Date:  2022-06-21       Impact factor: 0.500

3.  The Association of Type D personality with Heart Rate Variability and Lipid Profiles Among Patients with Coronary Artery Disease.

Authors:  I-Mei Lin; San-Yu Wang; I-Hua Chu; Ye-Hsu Lu; Chee-Siong Lee; Tsung-Hsien Lin; Sheng-Yu Fan
Journal:  Int J Behav Med       Date:  2017-02

4.  Blood Pressure Reactivity and Recovery to Anger Recall in Hypertensive Patients with Type D Personality.

Authors:  Yi-Da Li; Tin-Kwang Lin; Yi-Ru Tu; Chih-Wei Chen; Chin-Lon Lin; Ming-Nan Lin; Malcolm Koo; Chia-Ying Weng
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

5.  A pilot-study to assess the feasibility and acceptability of an Internet-based cognitive-behavior group therapy using video conference for patients with coronary artery heart disease.

Authors:  Tin-Kwang Lin; Pao-Ta Yu; Lian-Yu Lin; Ping-Yen Liu; Yi-Da Li; Chiu-Tien Hsu; Yih-Ru Cheng; Chun-Yin Yeh; Shu-Shu Wong; Shih-An Pai; Huey-Ling Shee; Chia-Ying Weng
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.